Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies

Clinical Microbiology and Infection

Volumn 8, Issue 2, 2002, Pages 101-111

  Jones, M E ^a,f   Gesu, G ^c   Ortisi, G ^d   Sahm, D F ^b   Critchley, I A ^b   Goglio, A ^e  

^a Focus Technologies Inc   (Netherlands)

^b Focus Technologies Incorporated   (United States)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e Ospedale Reuniti   (Italy)

^f Focus Technologies   (Netherlands)

Author keywords

Glycopeptides; Proficiency testing; Resistance

Indexed keywords

GLYCOPEPTIDE; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL LABORATORY; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; DEVICE; DIAGNOSTIC ACCURACY; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; ERROR; ITALY; METHODOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPECIES IDENTIFICATION; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS HAEMOLYTICUS;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS HAEMOLYTICUS;

EID: 0036463123     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2002.00378.x     Document Type: Article

References (32)

1. Glycopeptide-resistant enterococci: A decade of experience
2. Vancomycin-resistant enterococci
3. Antimicrobial resistance in key bloodstream bacterial isolates: Electronic surveillance with the Surveillance Network Database - USA
4. Clinical prevalence, antimicrobial susceptibility and geographic resistance patterns of enterococci: Results from the SENTRY antimicrobial surveillance program, 1997-1999
5. Antimicrobial susceptibility patterns of enterococci causing infections in Europe
6. Vancomycin susceptibility in Enterococcal blood isolates in Italy: A multicenter retrospective analysis
7. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147
8. Regulation of VanB-type vancomycin resistance gene expression by the VanS (B) -VanR (B) two-component regulatory system in Enterococcus faecalis V583
9. Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine: D-alanine ligase-related protein necessary for vancomycin resistance
10. VanD-type glycopeptide-resistant Enterococcus faecium BM4339
11. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405
12. Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis
13. Teicoplanin-resistant coagulase negative staphylococci
14. In vitro teicoplanin resistance in coagulase negative staphylococci from patients with endocarditis and from a cardiac surgery unit
15. Emergence of vancomycin resistance in coagulase-negative staphylococci
16. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
17. Update. Staphylococcus aureus with reduced susceptibility to vancomycin - United States 1997
18. Heterogeneous resistance to vancomycin in Staphylococcus aureus
19. First clinical Isolate of vancomycin intermediate Staphylococcus aureus in a French hospital
20. Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. Sentry Antimicrobial Surveillance Program
21. Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci
22. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides
23. Bacteriology
24. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR
25. Proficiency of Clinical Microbiology laboratories in Spain in detecting vancomycin-resistant Enterococcus spp
26. An interprovincial external quality assessment of the ability of Canadian laboratories to detect the vancomycin and penicillin resistance of Enterococcus faecium D366
27. Proficiency testing Spanish laboratories in detecting vancomycin resistance
28. Ability of laboratories to detect emerging antimicrobial resistance: Proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing
29. Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci
30. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci